HighGravityDataHumana — Apr 30, 2025 release
Fiscal 2025 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000049071-25-000021
Showing in the filing
GAAP EPS
“approximately $14.68”
Period
FY2025
Measure
GAAP-tied
Source
Prose
All guidance in this release · 22
GAAP EPS for FY2025
“approximately $14.68”
Insurance segment benefit ratio for FY2025
“90.1 percent to 90.5 percent”
Adjusted FY 2025 EPS for FY2025
“approximately $16.25”
Diluted earnings per share (EPS) - Adjusted … for FY2025
“approximately $16.25”
Diluted earnings per common share (EPS) GAAP for FY2025
“approximately $14.68 (previously approximately $15.88)”
Diluted earnings per share (EPS) - GAAP for FY2025
“approximately $14.68”
Total Revenues Consolidated - GAAP for FY2025
“$126 billion to $128 billion”
Total Revenues Insurance segment - GAAP for FY2025
“$121 billion to $123 billion”
Total Revenues CenterWell segment - GAAP for FY2025
“$20.5 billion to $21.5 billion”
Change in year-end medical membership - Indi… for FY2025
“Decline of approximately 550,000”
Individual Medicare Advantage annual members… for FY2025
“approximately 550,000”
Change in year-end medical membership - Grou… for FY2025
“Relatively flat”
Change in year-end medical membership - Medi… for FY2025
“Growth of approximately 200,000”
Change in year-end medical membership - Stat… for FY2025
“Growth within 175,000 to 250,000 range”
Operating Cost Ratio - Consolidated GAAP for FY2025
“11.3% to 11.7%”
Segment Results - Insurance segment income f… for FY2025
“$1.5 billion to $2.0 billion”
CenterWell segment income from operations - … for FY2025
“$1.0 billion to $1.5 billion”
CenterWell segment income from operations - … for FY2025
“$1.2 billion to $1.7 billion”
Effective Tax Rate - GAAP for FY2025
“approximately 25.0%”
Weighted Avg. Share Count for Diluted EPS for FY2025
“approximately 121.5 million”
Cash flows from operations - GAAP for FY2025
“$2.4 billion to $2.9 billion”
Capital expenditures for FY2025
“approximately $650 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Box 1438 Louisville, KY 40202 http://www.humana.com FOR MORE INFORMATION CONTACT: Lisa Stoner Humana Investor Relations (502) 580-2652 e-mail: LStamper@humana.com Mark Taylor Humana Corporate Communications (317) 753-0345 e-mail: MTaylor108@humana.com Humana Reports First Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted Financial Guidance • Reports 1Q25 earnings per share (EPS) of $10.30 on a GAAP basis, Adjusted EPS of $11.58 • 1Q25 Insurance segment benefit ratio of 87.4 percent, in line with the company's previously disclosed expectation of 'approximately 87.5 percent' • Affirms Adjusted FY 2025 EPS guidance of 'approximately $16.25'; while revising GAAP EPS to 'approximately $14.68' from the previous estimate of 'approximately $15.88' • Affirms FY 2025 Insurance segment benefit ratio guidance range of 90.1 percent to 90.5 percent • Affirms expected individual Medicare Advantage annual membership decline of approximately 550,000, inclusive of the impact of exiting certain unprofitable plans and counties ◦ Remains confident in 2025 pricing strategy as the company prioritizes membership that is expected to drive sustainable, long-term value creation • Continues to advance the company's long-term strategy with achievements within the CenterWell and Medicaid businesses ◦ CenterWell Pharmacy selected as the fulfillment pharmacy for NovoCare ® Pharmacy’s weight loss medication for cash pay customers ◦ Illinois announced its intent to award the company a contract for the state's new Fully Integrated Dual Eligible Special Needs Plan program • Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 8:00 a.m. ET question and answer session to discuss its financial results for the quarter and expectations for future earnings LOUISVILLE, KY (April 30, 2025) – Humana Inc. (NYSE: HUM) today reported consolidated pretax res
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.